[Skip to Content]
[Skip to Content Landing]
June 1960

Hydriodic Acid-Induced Myxedema Followed by Recovery and Thyroidal Failure

Author Affiliations

Los Angeles; Boston

From the Thorndike Memorial Laboratory and Second and Fourth (Harvard) Medical Services, Boston City Hospital, the Department of Medicine, Harvard Medical School, Boston, the Department of Medicine, Veterans Administration Center, Los Angeles, and the Department of Medicine, University of California Medical Center, Los Angeles.; Fellow in Pathology, Department of Pathology, New York University College of Medicine, and formerly Intern, Second and Fourth Medical (Harvard) Services, Boston City Hospital (Dr. Becker).

AMA Arch Intern Med. 1960;105(6):884-890. doi:10.1001/archinte.1960.00270180062008

Despite widespread use of potassium iodide and syrup of hydriodic acid in pulmonary disease, goiter and myxedema are rare and only recently described complications of iodide therapy. The possibility exists that when hypothyroidism and goiter do develop during treatment with iodide-containing medicine, some preexisting defect in thyroidal metabolism may result in marked sensitivity to an antithyroid action of iodide. In an attempt to demonstrate such an abnormality, several techniques have been applied to the study of a patient who developed flagrant myxedema during prolonged ingestion of syrup of hydriodic acid.

Report of a Case  A 67-year-old white widow was admitted to the hospital because of lethargy, intolerance to cold, and hoarseness. One year prior to admission she developed a chronic cough for which she was given syrup of hydriodic acid. Although her cough subsided, she continued to take 6 teaspoonfuls of the syrup daily (420 mg. of hydriodic acid) until

Mean and standard deviation.
Dowling, J. T.; Freinkel, N., and Ingbar, S. H.:  Thyroxine-Binding by Sera of Pregnant Women, Newborn Infants, and Women with Spontaneous Abortion ,  J. Clin. Invest. 35:1263-1276, 1956.Crossref
Ingbar, S. H.:  Simultaneous Measurement of the Iodide-Concentrating and Protein-Binding Capacities of the Normal and Hyperfunctioning Human Thyroid Gland ,  J. Clin. Endocrinol. 15: 238-264, 1955.Crossref
Ingbar, S. H.; Freinkel, N.; Hoeprich, P. D., and Athens, J. W.:  The Concentration and Significance of the Butanol-Extractable I131 of Serum in Patients with Diverse States of Thyroidal Function ,  J. Clin. Invest. 33:388-399, 1954.Crossref
Martin, K. A.:  The Conditions Under Which Iodin Will Cause a Change in the Basal Metabolic Rate in Man: Its Occurrence in Conditions Other than That of Graves' Disease ,  Am. J.M. Sc. 174: 648-660, 1927.
Koehler, A. E.:  Medication in Hypothyroidism ,  Am. Clin. M. 5:635-638, 1928.
Haines, S. F.:  Exophthalmic Goiter and Myxedema: Report of a Case ,  Endocrinology 12: 55-58, 1928.Crossref
Proger, S., and Brauns, W. H.:  Myxedema Following Iodine Treatment for Hyperthyroidism ,  Bull. New England M. Center 5:42-47, 1943.
Thompson, W. O.; Thompson, P. K.; Brailey, A. G., and Cohen, A. C.:  Myxedema During the Administration of Iodin in Exophthalmic Goiter ,  Am. J.M. Sc. 179:733-750, 1930.
Skillern, P. G.; Crile, G., Jr.; McCullagh, E. P.; Hazard, J. B.; Lewis, L. A., and Brown, H.:  Struma Lymphomatosa: Primary Thyroid Failure with Compensatory Thyroid Enlargement ,  J. Clin. Endocrinol. 16:35-54, 1956.Crossref
Morgans, M. E., and Trotter, W. R.:  Defective Organic Binding of Iodine by the Thyroid in Hashimoto's Thyroiditis ,  Lancet 1:553-555, 1957.Crossref
Bongiovanni, A. M.; Eberlein, W. R.; Thomas, P. Z., and Anderson, W. B.:  Sporadic Goiter of the Newborn ,  J. Clin. Endocrinol. 16: 146-152, 1956.Crossref
Stanley, M. M.:  The Direct Estimation of the Rate of Thyroid Hormone Formation in Man: The Effect of the Iodide Ion on Thyroid Iodine Utilization ,  J. Clin. Endocrinol. 9:941-954, 1949.Crossref
Childs, D. S., Jr.; Keating, F. R., Jr.; Rall, J. E.; Williams, M. M. D., and Power, M. H.:  The Effect of Varying Quantities of Inorganic Iodide (Carrier) on the Urinary Excretion and Thyroid Accumulation of Radioiodine in Exophthalmic Goiter ,  J. Clin. Invest. 29:726-738, 1950.Crossref
Stanley, M. M., and Astwood, E. B.:  The Accumulation of Radioactive Iodide by the Thyroid Gland in Normal and Thyrotoxic Subjects and the Effect of Thiocyanate on Its Discharge ,  Endocrinology 42:107-123, 1948.Crossref
Strouse, S., and Binswanger, H. F.:  The Symptom Complex Resembling Hyperthyroidism Without Increased Metabolism ,  J.A.M.A. 88:161-164, 1927.Crossref
Keating, F. R., Jr.; Haines, S. F.; Power, M. H., and Williams, M. M. D.:  The Radioiodine-Accumulating Function of the Human Thyroid Gland as a Diagnostic Test in Clinical Medicine ,  J. Clin. Endocrinol. 10:1425-1464, 1950.Crossref
Wolff, J., and Chaikoff, I. L.:  Plasma Inorganic Iodide as a Homeostatic Regulator of Thyroid Function ,  J. Biol. Chem. 174:555-564, 1948.
Morton, M. E.; Chaikoff, I. L., and Rosenfeld, S.:  Inhibiting Effect of Inorganic Iodide on Formation in Vitro of Thyroxine and Diiodotyrosine by Surviving Thyroid Tissue ,  J. Biol. Chem. 154:381-387, 1944.
Bell, G. O.:  Prolonged Administration of Iodine in the Pathogenesis of Simple Goiter and Myxedema ,  Tr. Am. Goiter A. (1952) pp. 28-37, 1953.
Turner, H. H., and Howard, R. B.:  Goiter from Prolonged Ingestion of Iodide ,  J. Clin. Endocrinol. 16:141-145, 1956.Crossref
Morgans, M. E., and Trotter, W. R.:  Two Cases of Myxedema Attributed to Iodide Administration ,  Lancet 2:1335-1337, 1953.Crossref
Raben, M. S.:  Endocrine Conference: Case History ,  J. Clin. Endocrinol. 13:469-472, 1953.Crossref
Goldner, M.:  Clinical Conference on Metabolic Problems: Iodide-Myxedema ,  Metabolism 4:545-551, 1955.
Hydovitz, J. D., and Rose, E.:  Goiter and Myxedema Following Prolonged Ingestion of Iodine: Report of a Case with Evidence of Unusual Thyroid Dysfunction ,  J. Clin. Endocrinol. 16:1109-1116, 1956.Crossref
Paley, K. R.; Sobel, E. S., and Yalow, R. S.:  Some Aspects of Thyroidal Iodine Metabolism in Iodine-Induced Hypothyroidism ,  J. Clin. Endocrinol. 18:79-90, 1958.Crossref
Rubinstein, H. M., and Oliner, L.:  Myxedema Induced by Prolonged Iodide Administration ,  New England J. Med. 256:47-52, 1957.Crossref